SG11201610857TA - Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof - Google Patents

Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof

Info

Publication number
SG11201610857TA
SG11201610857TA SG11201610857TA SG11201610857TA SG11201610857TA SG 11201610857T A SG11201610857T A SG 11201610857TA SG 11201610857T A SG11201610857T A SG 11201610857TA SG 11201610857T A SG11201610857T A SG 11201610857TA SG 11201610857T A SG11201610857T A SG 11201610857TA
Authority
SG
Singapore
Prior art keywords
generating
methods
same
stem cells
cultured mammalian
Prior art date
Application number
SG11201610857TA
Inventor
Kang Zhang
Hong Quyang
Rui Hou
Huimin Cai
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SG11201610857TA publication Critical patent/SG11201610857TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases (EC 2.)
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
SG11201610857TA 2014-06-27 2015-06-29 Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof SG11201610857TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462018396P 2014-06-27 2014-06-27
PCT/US2015/038384 WO2015200920A1 (en) 2014-06-27 2015-06-29 Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof

Publications (1)

Publication Number Publication Date
SG11201610857TA true SG11201610857TA (en) 2017-01-27

Family

ID=54938873

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201610857TA SG11201610857TA (en) 2014-06-27 2015-06-29 Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
SG10201806498RA SG10201806498RA (en) 2014-06-27 2015-06-29 Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201806498RA SG10201806498RA (en) 2014-06-27 2015-06-29 Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof

Country Status (10)

Country Link
US (1) US20170233698A1 (en)
EP (1) EP3161127A4 (en)
JP (1) JP2017522016A (en)
KR (1) KR20170020527A (en)
CN (1) CN107075469A (en)
CA (1) CA2953524A1 (en)
IL (1) IL249828A0 (en)
MX (1) MX2017000181A (en)
SG (2) SG11201610857TA (en)
WO (1) WO2015200920A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4036228A1 (en) * 2015-11-13 2022-08-03 Avellino Lab USA, Inc. Methods for the treatment of corneal dystrophies
KR101645901B1 (en) * 2015-12-31 2016-08-04 가톨릭대학교 산학협력단 Method for culturing limbal stem cell using amniotic membrane slide scaffold
CN106011065B (en) * 2016-07-15 2019-08-02 江苏大学 Human eye bulbar conjunctiva triangular mass of mucous membrane growing from the inner corner of the eye stem cells strain
CN106591220A (en) * 2016-12-29 2017-04-26 深圳市永生原代细胞生物科技有限公司 Human normal skin epithelial cell and use thereof
WO2018131491A1 (en) * 2017-01-13 2018-07-19 国立大学法人大阪大学 Method for producing corneal epithelial cell mass
US11851659B2 (en) 2017-03-22 2023-12-26 Novartis Ag Compositions and methods for immunooncology
WO2020018868A1 (en) * 2018-07-19 2020-01-23 Texas Tech University System Corneal epithelial cells and their products for treating corneal diseases
CN109321599B (en) * 2018-09-27 2023-08-22 同济大学 Construction and application of lineage tracing system in human pluripotent stem cells
UY38427A (en) * 2018-10-26 2020-05-29 Novartis Ag METHODS AND COMPOSITIONS FOR EYE CELL THERAPY
WO2020160197A1 (en) * 2019-01-29 2020-08-06 The Regents Of The University Of California Novel treatments of glaucoma
CN109897823A (en) * 2019-01-31 2019-06-18 华中科技大学 A method of tissue engineering comea edge is prepared based on Matrigel
JP2022528737A (en) * 2019-04-01 2022-06-15 ステムサイト オイ How to Obtain or Maintain ABCG2-Positive Corneal Ring Stem Cells
WO2021009778A2 (en) * 2019-07-18 2021-01-21 Pandorum Technologies Private Limited Methods for culturing mesenchymal stem cells, products thereof, and applications thereof
US20220265659A1 (en) * 2019-09-02 2022-08-25 Inserm (Institut National De La Santé Et De Al Recherche Médicale) Methods and compositions for treating pax6-deficiency related disease
EP4054595A4 (en) * 2019-11-07 2023-11-15 Massachusetts Eye and Ear Infirmary Cultivated autologous limbal epithelial cell (calec) transplantation
CN111500526B (en) * 2020-03-31 2022-02-18 厦门大学 Composition for in-vitro culture of primary mouse corneal epithelial cells and application thereof
CN115667504A (en) * 2020-04-27 2023-01-31 诺华股份有限公司 Methods and compositions for ocular cell therapy
CN113736735B (en) * 2020-05-27 2024-02-20 深圳华大生命科学研究院 Method and kit for in vitro induction of limbal-like stem cells
WO2022139573A1 (en) * 2020-12-23 2022-06-30 Universiti Kebangsaan Malaysia A corneal-healing device and method for producing the same
CN112626019A (en) * 2020-12-28 2021-04-09 武汉爱尔眼科医院有限公司 Preparation method of single cell suspension of cornea and corneal limbus
CN115068504A (en) * 2021-03-12 2022-09-20 广州康睿生物医药科技股份有限公司 Cornea repairing material and preparation method and application thereof
WO2023182856A1 (en) * 2022-03-24 2023-09-28 서울대학교산학협력단 Pharmaceutical composition including rho-kinase inhibitor for prevention or treatment of cutaneous fibrotic disorders such as keloid, etc. and use thereof
CN115094038A (en) * 2022-07-15 2022-09-23 中国医学科学院北京协和医院 Primary culture method of corneal stromal cells
PL442250A1 (en) * 2022-09-12 2024-03-18 Acellmed Spółka Z Ograniczoną Odpowiedzialnością Fibrin dressing containing corneal epithelial cells and method of producing the dressing

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314960A (en) 1990-04-10 1994-05-24 Permeable Technologies, Inc. Silicone-containing polymers, oxygen permeable hydrophilic contact lenses and methods for making these lenses and treating patients with visual impairment
US5057578A (en) 1990-04-10 1991-10-15 E. I. Du Pont De Nemours And Company Silicone-containing block copolymers and macromonomers
US5371147A (en) 1990-10-11 1994-12-06 Permeable Technologies, Inc. Silicone-containing acrylic star polymers, block copolymers and macromonomers
US6011029A (en) 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
EP0956865B2 (en) 1996-08-12 2010-08-18 Mitsubishi Tanabe Pharma Corporation MEDICINES COMPRISING Rho KINASE INHIBITOR
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US7217722B2 (en) 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
HN2002000067A (en) 2001-03-23 2003-10-24 Bayer Healthcare Llc INHIBITORS OF THE RHO - QUINASA.
AU2002305205A1 (en) 2001-04-20 2002-11-05 Jingrong Cao 9-deazaguanine derivatives as inhibitors of gsk-3
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
WO2003030959A1 (en) * 2001-10-06 2003-04-17 Btg International Limited Corneal repair device
AU2002360405A1 (en) 2001-11-19 2003-06-10 Iconix Pharmaceuticals, Inc. Modulators of rho c activity
WO2003059913A1 (en) 2002-01-10 2003-07-24 Bayer Healthcare Ag Roh-kinase inhibitors
WO2003062227A1 (en) 2002-01-23 2003-07-31 Bayer Pharmaceuticals Corporation Rho-kinase inhibitors
JP4469179B2 (en) 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Pyrimidine derivatives as Rho kinase inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
GB0206860D0 (en) 2002-03-22 2002-05-01 Glaxo Group Ltd Compounds
WO2003082808A1 (en) 2002-04-03 2003-10-09 Sumitomo Pharmaceuticals Company, Limited. Benzamide derivatives
ES2273047T3 (en) 2002-10-28 2007-05-01 Bayer Healthcare Ag PHENYLAMINOPIRIMIDINES REPLACED WITH HETEROARILOXI AS INHIBITORS OF RHO-CINASA.
ES2374272T3 (en) 2003-06-19 2012-02-15 Glaxosmithkline Llc DERIVATIVES OF 5- (ACILAMINE) INDAZOL AS QUINASE INHIBITORS.
EP1644365A2 (en) 2003-07-02 2006-04-12 Biofocus Discovery Ltd Pyrazine and pyridine derivatives as rho kinase inhibitors
CN1289156C (en) * 2003-07-25 2006-12-13 吕伟光 Tissue engineering autologous cornea epithelium and its preparation method
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
CN1590541A (en) * 2004-05-27 2005-03-09 天津医科大学眼科中心 Cornea edge stem cell tissue engineering composite body and its preparation method
AU2006346492A1 (en) * 2006-07-24 2008-01-31 International Stem Cell Corporation Synthetic cornea from retinal stem cells
CN101121926A (en) * 2007-07-02 2008-02-13 西北农林科技大学 Limbus corneae stem cell serum-free culture medium
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
HRP20230650T1 (en) * 2009-02-03 2023-09-29 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells
US20110171180A1 (en) * 2009-03-19 2011-07-14 Worcester Polytechnic Institute Bioengineered skin substitutes
GB0908927D0 (en) * 2009-05-22 2009-07-01 Univ Reading The Synthetic graft
DK2638149T3 (en) 2010-11-12 2019-08-12 Univ Georgetown IMMORTALIZATION OF EPITHEL CELLS AND METHODS OF USE
JP5759536B2 (en) * 2011-04-20 2015-08-05 国立大学法人大阪大学 Corneal epithelial differentiation-directed iPS cells
JP2013000121A (en) * 2011-06-16 2013-01-07 Tokyo Women's Medical College Epithelial cell culture medium, method for culturing epithelial cell using the same, and epithelial cell obtained therefrom
ES2667620T3 (en) * 2011-07-15 2018-05-11 Osaka University Method to prepare a corneal endothelial cell
WO2013061608A1 (en) * 2011-10-27 2013-05-02 国立大学法人東京医科歯科大学 Technique for isolating/culturing colorectal epithelial stem cell, and technique for transplanting colorectal epithelium employing said technique
JP5991368B2 (en) * 2012-03-16 2016-09-14 株式会社日立製作所 Cell sheet, cell culture method and cell culture apparatus
CN102952779B (en) * 2012-11-30 2014-07-16 山东大学 Cultural method for inducing human embryonic stem cell to directionally differentiate into corneal limbal stem cell
CN103053511A (en) * 2012-12-10 2013-04-24 山东省眼科研究所 Cornea metaphase preservation solution, and preparing and using methods thereof

Also Published As

Publication number Publication date
JP2017522016A (en) 2017-08-10
EP3161127A4 (en) 2018-06-06
MX2017000181A (en) 2017-05-01
IL249828A0 (en) 2017-02-28
WO2015200920A8 (en) 2017-04-06
EP3161127A1 (en) 2017-05-03
KR20170020527A (en) 2017-02-22
CA2953524A1 (en) 2015-12-30
WO2015200920A1 (en) 2015-12-30
CN107075469A (en) 2017-08-18
US20170233698A1 (en) 2017-08-17
SG10201806498RA (en) 2018-08-30

Similar Documents

Publication Publication Date Title
IL249828A0 (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
HK1246342A1 (en) METHODS FOR GENERATING STEM CELL-DERIVED ß CELLS AND USES THEREOF
IL249150A0 (en) Methods for harvesting mammalian cell cultures
MA39819A (en) Methods and compositions for immunomodulation
SG10201810150UA (en) Compositions and methods for enhanced gene expression in cone cells
EP3150704A4 (en) Culture method and cell mass
GB201611982D0 (en) Cell culture
EP3223831A4 (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
EP3383182A4 (en) Methods for generating functional hematopoietic stem cells
SG11202004935UA (en) Cell culture methods
HK1247639A1 (en) Medium composition for culturing stem cells
EP3202896A4 (en) Method for culturing pluripotent stem cells
IL246525A0 (en) Pomegranate derived cell culture and methods for preparing and using the same
SG11201610878QA (en) Mutant hemagglutinin complex protein, and method for culturing pluripotent stem cells using same
EP3205710A4 (en) Cell culture bag and cell culture method
IL270880A (en) Cell culture methods
IL261999A (en) Cell culture process
EP3194573A4 (en) Mammalian pluripotent stem cells, methods for their production, and uses thereof
EP3183333A4 (en) Primary mammalian cell culture systems and methods
PL3287521T3 (en) Cell culture
HK1254737A1 (en) Stem cell culturing method
IL250293A0 (en) Method for preparing induced pluripotent stem cell line from mesenchymal stem cells, and cell line obtained thereby
EP3144384A4 (en) Method for inducing cell reprogramming, and method for producing pluripotent cells
EP3651779A4 (en) Methods for generating pluripotent stem cells
SG10202010002RA (en) Cell culture